Model selection for successful AI-based innovation adoption

, , ,
Build your own, buy off-the-shelf, or a hybrid version of both? The life sciences industry is experiencing a wave of growth driven by innovative technologies and advanced research. COVID-19 has further cemented the strength of the industry…

A roundtable discussion with Pharma Executives: summary and takeaways

, ,
By Doron Aspitz, Verix CEO   Recently, we hosted an Executive Round Table session that focused on the challenges of customer-centric marketing in the Pharma industry and the use of artificial intelligence techniques to connect strategy…

Forecasting Future Sales, From the Bottom Up

, ,
Forecasting Future Sales, From the Bottom Up An AI/ML approach to precision forecasting for the Pharma industry Much goes into the setting of sales goals and strategizing on how to achieve them. Sales estimates are projected based on a complex…

How to grasp a significant stake of your pharma market?

, , ,
How to grasp a significant stake of your pharma market? From effective strategy to efficient execution The pharmaceutical marketing landscape is extremely dynamic and ever-evolving, with shifts drastically influencing how pharmaceutical companies…

Unleashing the power of AI/ML by upskilling business users

,
The emerging role of citizen data scientist in Pharma Commercial Operations.   Pharma and biotech companies, especially those introducing first-in-class Specialty & Oncology drugs, with added complexity such as novel mechanisms…
Failure blog post

Why are so many AI projects doomed for failure?

,
The elephant in the room is actually human By Shahar Cohen, PhD, Head of Verix AI Lab.   One of my first data science projects sought to improve the targeting process of a sales organization. Before we came in, sales reps were expected…

Commercialising AI: Are We There Yet?

, , ,
The business case for wholesale adoption of AI doesn’t need to be made. But how far along is pharma? Advanced analytics and machine learning are the words on everyone’s lips in pharma right now. Companies big and small are…